Changes in physical fitness in acute leukemia patients during chemotherapy
Schölvinck, A. M., de Graaff, B. M. B., van den Beld, M. J. & Broerse, J. E. W. Research in haematological cancers: what do patients in the Netherlands prioritise? Eur. J. Cancer Care. 28, e12989. (2019).
Google Scholar
Rose-Inman, H., Kuehl, D., Acute & Leukemia Hematol. Oncol. Clin. N. Am. 31, 1011–1028, doi: (2017).
Google Scholar
Leak Bryant, A. et al. Perceived benefits and barriers to Exercise for recently treated adults with Acute Leukemia. Oncol. Nurs. Forum. 44, 413–420. (2017).
Google Scholar
Caspersen, C. J., Powell, K. E. & Christenson, G. M. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public. Health Rep. 100, 126–131 (1985).
Google Scholar
Ferguson, B. ACSM’s Guidelines for Exercise Testing and Prescription 9th EdVol. 58 (Canadian Chiropractic Association, 2014).
Google Scholar
Crapo, R. et al. ATS statement: guidelines for the six-Minute Walk Test. Am. J. Resp. Crit. Care. 166, 111–117. (2002).
Google Scholar
Roberts, H. C. et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 40, 423–429. (2011).
Google Scholar
Ross, R. et al. Importance of assessing Cardiorespiratory Fitness in Clinical Practice: a case for fitness as a Clinical Vital sign: A Scientific Statement from the American Heart Association. Circulation 134, e653–e699. (2016).
Google Scholar
Kirkham, A. A. et al. Health-related physical fitness assessment in a community-based cancer rehabilitation setting. Supportive care cancer: Official J. Multinational Association Supportive Care Cancer. 23, 2525–2533. (2015).
Google Scholar
Vermaete, N., Wolter, P., Verhoef, G. & Gosselink, R. Physical activity and physical fitness in lymphoma patients before, during, and after chemotherapy: a prospective longitudinal study. Ann. Hematol. 93, 411–424. (2014).
Google Scholar
Engel, G. L. The need for a new medical model: a challenge for biomedicine. Sci. (New York N Y). 196, 129–136. (1977).
Google Scholar
Rothman, M. L., Beltran, P., Cappelleri, J. C., Lipscomb, J. & Teschendorf, B. Patient-reported outcomes: conceptual issues. Value Health: J. Int. Soc. Pharmacoeconomics Outcomes Res. 10 (Suppl 2), 66–75. (2007).
Google Scholar
U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U. S. D. o. H. a. H. S. F. C. f. B. E. a. R. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual. Life Outcomes. 4 (2006).
Wiklund, I. Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life. Fundam. Clin. Pharmacol. 18, 351–363. (2004).
Google Scholar
Doward, L. C., Gnanasakthy, A. & Baker, M. G. Patient reported outcomes: looking beyond the label claim. Health Qual. Life Outcomes. 8 (2010).
Paterson, C., Thomas, K., Manasse, A., Cooke, H. & Peace, G. Measure yourself concerns and wellbeing (MYCaW): an individualised questionnaire for evaluating outcome in cancer support care that includes complementary therapies. Complement. Ther. Med. 15, 38–45. (2007).
Google Scholar
Greenhalgh, J., Long, A. F. & Flynn, R. The use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory? Social science & medicine (1982) 60, 833–843 (2005).
Strand, V. et al. Endpoints: consensus recommendations from OMERACT IV. Outcome measures in Rheumatology. Lupus 9, 322–327. (2000).
Google Scholar
Lenz, E. R., Suppe, F., Gift, A. G., Pugh, L. C. & Milligan, R. A. Collaborative development of middle-range nursing theories: toward a theory of unpleasant symptoms. ANS Adv. Nurs. Sci. 17, 1–13. (1995).
Google Scholar
Lenz, E. R., Pugh, L. C., Milligan, R. A., Gift, A. & Suppe, F. The middle-range theory of unpleasant symptoms: an update. ANS Adv. Nurs. Sci. 19, 14–27. (1997).
Google Scholar
Brunner, A. M. et al. Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemia. Am. J. Hematol. 88, 642–646. (2013).
Google Scholar
Kempf, E. et al. Prognosis of body mass index and chemotherapy dose capping in acute myeloid leukaemia. Leuk. Res. 38, 1425–1429. (2014).
Google Scholar
Muller, K. E. & Barton, C. N. Approximate power for repeated-measures ANOVA lacking sphericity. J. Am. Stat. Assoc. 84, 549–555. (1989).
Google Scholar
Naik, D. N. & Rao, S. S. Analysis of multivariate repeated measures data with a Kronecker product structured covariance matrix. J. Appl. Stat. 28, 91–105. (2001).
Google Scholar
Lin, M., Jiang, X. & Hu, R. Development and validation of the patient-reported outcomes instrument for acute leukemia. Chin. J. Nurs. 54, 350–355. (2019).
Google Scholar
Bower, J. E. Cancer-related fatigue–mechanisms, risk factors, and treatments. Nat. Rev. Clin. Oncol. 11, 597–609. (2014).
Google Scholar
Menshadi, N., Bar-Tal, Y. & Barnoy, S. The relationship between learned resourcefulness and cancer-related fatigue in patients with non-hodgkin lymphoma. Oncol. Nurs. Forum. 40, 133–138. (2013).
Google Scholar
Bryant, A. L. et al. The effects of Exercise on patient-reported outcomes and performance-based physical function in adults with Acute Leukemia undergoing induction therapy: Exercise and Quality of Life in Acute Leukemia (EQUAL). Integr. cancer Ther. 17, 263–270. (2018).
Google Scholar
Zhang, J. et al. Factors that influence the efficacy of acarbose and metformin as initial therapy in Chinese patients with newly diagnosed type 2 diabetes: a subanalysis of the MARCH trial. Curr. Med. Res. Opin. 32, 713–719. (2016).
Google Scholar
Xie, M. et al. Barriers to seeking psychosocial support among adult patients with hematologic neoplasms: a qualitative study. Supportive care cancer: Official J. Multinational Association Supportive Care Cancer. 30, 2613–2620. (2022).
Google Scholar
Virchis, A. et al. Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes. Br. J. Haematol. 124, 26–32. (2004).
Google Scholar
Galinsky, I., Coleman, M., Fechter, L. & Midostaurin Nursing perspectives on managing treatment and adverse events in patients with FLT3 mutation-positive Acute Myeloid Leukemia and Advanced systemic mastocytosis. Clin. J. Oncol. Nurs. 23, 599–608. (2019).
Google Scholar
Loteta, B. et al. Netupitant/palonosetron without dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous stem cell transplantation: a single-center experience. Supportive care cancer: Official J. Multinational Association Supportive Care Cancer. 30, 585–591. (2022).
Google Scholar
Kowaluk, A. & Wozniewski, M. Peak Oxygen Uptake and Exercise Capacity of children undergoing leukemia treatment. Int. J. Env Res. Pub He. 17, 8732. (2020).
Google Scholar
Alibhai, S. M. et al. A phase II exercise randomized controlled trial for patients with acute myeloid leukemia undergoing induction chemotherapy. Leuk. Res. 39, 1178–1186. (2015).
Google Scholar
Wehrle, A., Kneis, S., Dickhuth, H. H., Gollhofer, A. & Bertz, H. Endurance and resistance training in patients with acute leukemia undergoing induction chemotherapy-a randomized pilot study. Supportive care cancer: Official J. Multinational Association Supportive Care Cancer. 27, 1071–1079. (2019).
Google Scholar
Li, Y. et al. The role of mitochondrial Quality Control in Anthracycline-Induced Cardiotoxicity: from bench to Bedside. Oxidative Med. Cell. Longev. 3659278 (2022).
Bhagat, A., Kleinerman, E. S. & Anthracycline-Induced Cardiotoxicity Causes, mechanisms, and Prevention. Adv. Exp. Med. Biol. 1257, 181–192. (2020).
Google Scholar
Sakai, H. et al. Upregulation of ubiquitinated proteins and their degradation pathway in muscle atrophy induced by cisplatin in mice. Toxicol. Appl. Pharmcol. 403, 115165. (2020).
Google Scholar
Lin, K. Y. et al. Effects of Exercise in patients undergoing chemotherapy for Head and Neck Cancer: a pilot randomized controlled trial. Int. J. Env Res. Pub He. 18, 1291. (2021).
Google Scholar
Varedi, M., McKenna, R. & Lamberg, E. M. Balance in children with acute lymphoblastic leukemia. Pediatr. Int. 59, 293–302. (2017).
Google Scholar
Ness, K. K., Armenian, S. H., Kadan-Lottick, N. & Gurney, J. G. Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health. Expert Rev. Hematol. 4, 185–197. (2011).
Google Scholar
Mohamedali, H. et al. Older age is associated with similar quality of life and physical function compared to younger age during intensive chemotherapy for acute myeloid leukemia. Leuk. Res. 36, 1241–1248. (2012).
Google Scholar
Timilshina, N. et al. Long-term recovery of quality of life and physical function over three years in adult survivors of acute myeloid leukemia after intensive chemotherapy. Leukemia 33, 15–25. (2019).
Google Scholar
Fukushima, T. et al. Factors associated with muscle function in patients with hematologic malignancies undergoing chemotherapy. Supportive care cancer: Official J. Multinational Association Supportive Care Cancer. 28, 1433–1439. (2020).
Google Scholar
Chaber, R. et al. Body Mass Index (BMI) and Infectious/Febrile episodes in Children with Intermediate Risk Acute lymphoblastic leukemia (IR ALL). Nutr. Cancer. 71, 701–707. (2019).
Google Scholar
Meenan, C. K., Kelly, J. A., Wang, L., Ritchey, A. K. & Maurer, S. H. Obesity in pediatric patients with acute lymphoblastic leukemia increases the risk of adverse events during pre-maintenance chemotherapy. Pediatr. Blood Cancer. 66, e27515. (2019).
Google Scholar
Gendron, É. et al. The effect of cardiorespiratory fitness and physical activity levels on cognitive functions in survivors of childhood acute lymphoblastic leukemia. Pediatr. Hematol. Oncol. 37, 582–598. (2020).
Google Scholar
Lemay, V. et al. Prevention of Long-term adverse health outcomes with Cardiorespiratory Fitness and Physical Activity in Childhood Acute Lymphoblastic Leukemia survivors. J. Pediatr. Hematol. Oncol. 41 (e450-e458). (2019).
Orgel, E., Nabais, T., Douglas, C., Mittelman, S. D. & Neely, M. Effect of Body Fat on Population Pharmacokinetics of High-Dose Methotrexate in Pediatric patients with Acute Lymphoblastic Leukemia. J. Clin. Pharmacol. 61, 755–762. (2021).
Google Scholar
Cederholm, T., Eriksson, K. & Palmblad, J. Nutrition and acute leukemia in adults: relation to remission rate and survival. Haematologia 32, 405–417 (2002).
Google Scholar
Xu, W. et al. Effects of exercise interventions for physical fitness, fatigue, and quality of life in adult hematologic malignancy patients without receiving hematopoietic stem cell transplantation: a systematic review and meta-analysis. Supportive care cancer: Official J. Multinational Association Supportive Care Cancer. 30, 7099–7118. (2022).
Google Scholar
Zhou, Y., Zhu, J., Gu, Z. & Yin, X. Efficacy of Exercise interventions in patients with Acute Leukemia: a Meta-analysis. PloS One. 11, e0159966. (2016).
Google Scholar
Kouzi, S. A. & Uddin, M. N. Aerobic Exercise Training as a potential cardioprotective strategy to Attenuate Doxorubicin-Induced Cardiotoxicity. J. Pharm. Pharm. Sciences: Publication Can. Soc. Pharm. Sci. Societe canadienne des. Sci. Pharmaceutiques. 19, 399–410. (2016).
Google Scholar
Lemanne, D., Cassileth, B. & Gubili, J. The role of physical activity in cancer prevention, treatment, recovery, and survivorship. Oncol. (Williston Park N Y). 27, 580–585 (2013).
Schmitz, K. H. et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med. Sci. Sports. Exerc. 42, 1409–1426. (2010).
Google Scholar
Kampshoff, C. S. et al. Randomized controlled trial of the effects of high intensity and low-to-moderate intensity exercise on physical fitness and fatigue in cancer survivors: results of the resistance and endurance exercise after ChemoTherapy (REACT) study. BMC Med. 13, 275. (2015).
Google Scholar
link
